HITK News 43.49 Hi-Tech Pharmacal Co. (HITK)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Hi-Tech Pharmacal Co. (HITK) 43.49 $HITK

Akorn buys Hi-Tech Pharmacal for USD640m
M2 - 30 mins ago
Pharmaceutical company Akorn (NasdaqGS:AKRX) disclosed on Thursday the completion of the acquisition of Hi-Tech Pharmacal Co (NasdaqGS:HITK) for a purchase price of USD640m in cash.

Actavis to purchase four products from Akorn
M2 - 1 hr 41 mins ago
Pharmaceutical company Actavis (NYSE:ACT) reported on Thursday the launch of agreements to acquire four currently marketed products and one product under development from Akorn and Hi-Tech Pharmacal Co.

Akorn Completes Acquisition of Hi-Tech Pharmacal
Business Wire - Thu Apr 17, 8:20AM CDT
Akorn, Inc. (NASDAQ: AKRX), a niche pharmaceutical company, announced today that it has completed its previously announced acquisition of Hi-Tech Pharmacal Co., Inc. (NASDAQ: HITK) for $640 million in cash. The combination of Akorn and Hi-Tech will transform the Company into a larger, more diversified generic player. This combination also brings critical mass and scale to Akorn's business and strengthens the Company's position with retail and institutional customers.

Repligen Corporation Set to Join the S&P SmallCap 600
PR Newswire - Tue Apr 15, 4:53PM CDT
Repligen Corporation (NASD:RGEN) will replace Hi-Tech Pharmacal Co., Inc. (NASD:HITK) in the S&P SmallCap 600 after the close of trading on Thursday, April 17. S&P SmallCap 600 constituent Akorn Inc. (NASD:AKRX) is acquiring Hi-Tech Pharmacal Co. in a deal expected to be completed soon.

Akorn Receives FTC Clearance for Hi-Tech Pharmacal Acquisition
Business Wire - Mon Apr 14, 6:00PM CDT
Akorn, Inc. (NASDAQ: AKRX) today announced that the U.S. Federal Trade Commission (FTC) has voted to approve Akorn's acquisition of Hi-Tech Pharmacal Co., Inc. (NASDAQ: HITK). The unanimous vote in support of the transactions follows Akorn's agreement to a proposed consent order requiring divestiture of certain products as a condition to obtaining FTC approval. The parties have now obtained all regulatory approvals required to consummate the acquisition, and intend to close by the end of this week.

Hi-Tech Pharmacal Up 28.3% Since SmarTrend Uptrend Call (HITK)
Comtex SmarTrend(R) - Fri Apr 11, 4:57PM CDT
SmarTrend identified an Uptrend for Hi-Tech Pharmacal (NASDAQ:HITK) on June 19th, 2013 at $33.77. In approximately 10 months, Hi-Tech Pharmacal has returned 28.34% as of today's recent price of $43.34.

Shares of HITK Up 28.4% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Fri Apr 04, 11:07AM CDT
SmarTrend identified an Uptrend for Hi-Tech Pharmacal (NASDAQ:HITK) on June 19th, 2013 at $33.77. In approximately 10 months, Hi-Tech Pharmacal has returned 28.43% as of today's recent price of $43.37.

Hi-Tech Pharmacal Reports Sales of $59.9 Million for the Third Quarter Ended January 31, 2014
Business Wire - Tue Mar 11, 6:00AM CDT
Hi-Tech Pharmacal Co., Inc. (NASDAQ:HITK) today reported results for the third fiscal quarter ended January 31, 2014.

Hi-Tech Pharmacal Has Returned 28.2% Since SmarTrend Recommendation (HITK)
Comtex SmarTrend(R) - Thu Mar 06, 11:06AM CST
SmarTrend identified an Uptrend for Hi-Tech Pharmacal (NASDAQ:HITK) on June 19th, 2013 at $33.77. In approximately 9 months, Hi-Tech Pharmacal has returned 28.22% as of today's recent price of $43.30.

Akorn Guidance Worries Street As Strategy Hits Delays
at Investor's Business Daily - Mon Mar 03, 4:30PM CST
Specialty drugmaker Akorn's Q4 earnings met estimates Monday, but its 2014 guidance and a new accounting problem halted the IBD 50 stock dead in its tracks. Akorn (AKRX) said profit totaled 14 cents a share, up a penny from the year-earlier quarter...

Akorn Q4 Meets But Guidance Disappoints, Stock Down
at Investor's Business Daily - Mon Mar 03, 9:07AM CST
Specialty drugmaker Akorn (AKRX) Monday reported a Q4 in line with estimates, but it guided 2014 below expectations and shares plummeted 15% in early trading in the stock market today. The company said profit totaled 14 cents a share, up a penny from...

Hi-Tech Pharmacal Shares Up 28.4% Since SmarTrend's Buy Recommendation (HITK)
Comtex SmarTrend(R) - Thu Feb 27, 9:43AM CST
SmarTrend identified an Uptrend for Hi-Tech Pharmacal (NASDAQ:HITK) on June 19th, 2013 at $33.77. In approximately 8 months, Hi-Tech Pharmacal has returned 28.40% as of today's recent price of $43.36.

Youngevity International (YGYI) Inks Consulting Agreement with Creative Memories Co-Founder Rhonda Kanning Anderson
Business Wire - Wed Feb 26, 7:05AM CST
Youngevity International, Inc. (OTCQX: YGYI) (www.YGYI.com), a global direct marketer of nutritional and lifestyle products and also a vertically-integrated producer of gourmet coffees for the commercial, retail and direct sales channels, announced today that Rhonda Kanning Anderson will immediately begin advising the company on expanding its product offering in Scrap Books, Photo Albums, and Memory Books in both the digital and paper formats. Rhonda will have a keen focus on helping build the Heritage Makers Brand in the area of digital scrap booking as well as assist in the development and marketing of more traditionally oriented products for this space.

Actavis, Valeant, Jazz: New Roles For Specialty Pharma
at Investor's Business Daily - Fri Feb 07, 1:12PM CST
Last month, during an otherwise ho-hum conference call on 2014 financial guidance, Valeant Pharmaceuticals CEO Michael Pearson electrified the stock market by making an audacious promise. "Today we're introducing our sixth strategic initiative, which...
Scroll down for more posts ▼

Top 10 Most Recent News Articles

YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 210

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading
CureGene's CG-0416: Promising Weight Loss Breakthrough

Updated Category News Views 49

Game-Changer in Weight Management? Oh, the obesity world is buzzing, folks! There's some big noise coming from CureGene, and it's catching the attention of every lab-coat smarty in town. They just tossed out some preclinical data on CG-0416 at Obesity Week 2026 that could shake up how we tackle weight loss. Anyone still clinging to their old diet books might want to take...

Continue Reading
Championing Change: USTA Mid-Atlantic Gala's Impact

Updated Category News Views 360

A Night to Remember: USTA Mid-Atlantic's Gala Who would've thought tennis could wield such transformative power? This ain't your average sport gala. Last Saturday, a crowd of over 300 gathered at the Ritz-Carlton Tysons Corner for the USTA Mid-Atlantic Foundation's 2026 Tennis Creates Gala. Hosted by the formidable Malika Andrews, this event wasn't just a fancy...

Continue Reading
Kayla Harrison Dominates UFC 334, Earns Big Win

Updated Category News Views 64

Kicking off UFC 334 with a bang, Kayla Harrison didn't just step into the Octagon—she bulldozed her way through Amanda Nunes to retain her Women's Bantamweight Championship. This showdown didn't just electrify New York's Madison Square Garden, it shook the entire MMA landscape. Harrison, the face of Monster Energy's athlete roster, wasn't content with just defending her...

Continue Reading
HONOR Leads in China, Eyes Middle East Market

Updated Category News Views 0

A Force to be Reckoned With Talk about making waves—HONOR's got the bragging rights now. Sitting pretty at the top among Android smartphone brands in China ain't no small feat. We're looking at a snazzy 12.04% market share for October 2026, all thanks to selling a cool 2.573 million units. The kicker? This ain't even their full potential. They're hustling hard in the...

Continue Reading
KINGRVER Boosts RV Comfort with New Water Heater Lineup

Updated Category News Views 349

An Upgrade for the Open Road In the land of RV living, comfort is king—or in this case, KINGRVER. Dropping affordable upgrades for water heaters into the world of RVs, KINGRVER's CT6 lineup is like a warm hug on a chilly campsite morning. Whether you've pulled up to a wooded retreat or parked under the vast desert sky, having dependable hot water shouldn't be a gamble....

Continue Reading
Pony.ai & Toyota Launch 1,000 Gen-7 Robotaxis in China

Updated Category News Views 98

Revving Up the Autonomous Ride Revolution Not every day you see two giants, Pony.ai and Toyota, join forces to shake up the way folks get from A to B. But here we are — they’ve fired up their engines in Guangzhou, unleashing their Gen-7 bZ4X Robotaxis for commercial use. And let me tell you, this is no shot in the dark. With plans to dot about 1,000 of these...

Continue Reading
DoGo Power Revamps Energy for Remote Indonesian Isle

Updated Category News Views 16

Bringing Light to Pagerungan Kecil Island These days, if you wander into the fishing communities of Pagerungan Kecil Island, the buzz isn't just from the daily catch. Residents are talking about power, and not the kind you get from a generator spluttering along—I'm talking about a brand-new energy storage system that’s turning the lights on in ways these folks have...

Continue Reading
Guangdong's APEC Trade: Deep Ties, Big Stakes

Updated Category News Views 138

A New Chapter in Guangdong's Economic Story Swing by the bustling streets of Shenzhen, and you'll catch more than a whiff of change in the air. With China gearing up to host the APEC Economic Leaders' Meeting for the third time, Guangdong is under the magnifying glass. But it's not just the international attention landing on the province that’s worth the chatter —...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 548

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading

Top 5 Most Recently Viewed Articles

TuHURA Biosciences to Showcase Innovations at Major Investment Event

Updated Category News Views 109

TuHURA Biosciences to Present at Investment Conference TuHURA Biosciences, Inc. (NASDAQ: HURA), a pioneering Phase 3 immune-oncology company at the forefront of developing innovative therapeutics, has announced a significant presentation in the investment world. Management is set to showcase their work at the 27th Annual H.C. Wainwright Global Investment Conference, an...

Continue Reading
PennantPark Investment Corporation Enhances CLO Management Strategy

Updated Category News Views 123

PennantPark Investment Corporation Expands CLO Platform MIAMI — PennantPark Investment Corporation (the “Company”) (NYSE: PNNT) has successfully established a strong foothold in the middle market with the recent closing of a $400.5 million debt securitization through its joint venture, PennantPark Senior Loan Fund, LLC ("PSLF"). This significant achievement is part...

Continue Reading
Freeport-McMoRan Exceeds Earnings Expectations Amid Rising Copper Prices

Updated Category News Views 50

Freeport-McMoRan Exceeds Earnings Estimates In a recent financial report, Freeport-McMoRan (NYSE: FCX) showcased its ability to navigate the dynamic mining landscape, particularly benefitting from the surge in copper prices. The company announced a substantial profit that surpassed third-quarter expectations, drawing significant attention from investors and analysts...

Continue Reading
WellsCare and Celltrion Canada Unite for Pain Relief Solutions

Updated Category News Views 126

WellsCare Expands Reach with Celltrion Partnership WellsCare, a pioneering medical technology startup based in South Korea, has forged a promising alliance with Celltrion Canada, a renowned subsidiary of global biopharmaceutical giant Celltrion. This collaboration marks a significant milestone in the development of advanced wearable technology aimed at offering effective...

Continue Reading
Elon Musk Addresses Violence Concerns Amid Political Tensions

Updated Category News Views 524

Elon Musk Issues Stark Warning on Violence at Rally Elon Musk stirred significant debate after his virtual appearance at a far-right rally in the UK, where he alerted attendees to an impending threat of violence. His stark statement, "violence is coming, fight back, or die," has reverberated through political discussions and media outlets alike. Details of the Rally...

Continue Reading